Australian Government announces “patent box” scheme to boost medical and biotech innovation

Written By

rebecca currey module
Rebecca Currey

Partner
Australia

I am a partner in our Intellectual Property Group, based in Sydney. My experience spans the breadth and depth of IP issues, but my specialty is complex IP litigation and disputes including contentious patent, trade mark, copyright, and confidential information and consumer protection/passing-off matters.

patrick brown Module
Patrick Brown

Associate
UK

I am an Associate in our Intellectual Property Group in London, with a particular focus on the life sciences, pharmaceutical and chemical sectors.

The Australian Government has committed $206.4 million to a patent box tax incentive scheme to encourage investment in medical and biotechnology innovation.



Patent box schemes are a type of tax incentive where income from certain types of patents is taxed a preferential lower corporate tax rate. Australia will join over 20 other countries including the UK, France, China, Belgium and Switzerland in offering patent box type tax incentive schemes.

The scheme will come into effect from 1 July 2022 and will apply to granted patents that were filed after 11 May 2021. Although the details of the scheme are yet to be finalised, income derived solely from eligible…

Full article available on PatentHub

Latest insights

More Insights
Crowd from above

Setting up a business in France

Jul 31 2025

Read More
Curiosity line pink background

Hong Kong: A New Chapter in Medical Products Regulations

Jul 30 2025

Read More
featured image

UPC establishes jurisdiction over UK patent rights in landmark decision

5 minutes Jul 29 2025

Read More